Turn Therapeutics (TTRX) Total Current Liabilities (2024 - 2026)

Turn Therapeutics has reported Total Current Liabilities for 3 years, with the latest figure at $5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities changed N/A year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (changed N/A YoY), and the FY2025 full-year result was $6.0 million, up 748.02% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $5.1 million, down from $6.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $6.0 million in Q4 2025, with the low at $707932.0 in Q4 2024.
• Average Total Current Liabilities over 3 years is $3.5 million, with a median of $3.7 million recorded in 2025.
• Peak annual rise in Total Current Liabilities reached 748.02% in 2025, while the deepest fall reached 748.02% in 2025.
• Tracing TTRX's Total Current Liabilities over 3 years: stood at $707932.0 in 2024, then soared by 748.02% to $6.0 million in 2025, then decreased by 14.54% to $5.1 million in 2026.
• The last three Total Current Liabilities figures came in at $5.1 million (Q1 2026), $6.0 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison